Clinical Research News

How we adapt clinical research to biotech and pharma needs in Europe, with CHIM, ADME, biometrics and data innovation for faster insights.

Learn why so few Respiratory Syncytial Virus (RSV) models exist, what makes them so complex and how Antwerp emerged as a leading European hub for human challenge research.

Explore how Antwerp’s validated challenge models, GMP capabilities and clinical expertise create a true early phase advantage as Belgium extends accelerated timelines to CHIM trials, with approvals capped at 59 days.

Learn about ikbenpionier.be, our official platform for healthy volunteers at our CPU in Belgium, and how you can participate.

Explore how Belgium enables faster clinical trial start-ups and our SGS Clinical Pharmacology Unit improves early phase timelines and healthy volunteer enrollment.

Antwerp has emerged as Europe’s leading CHIM hub, combining accelerated Belgian regulatory timelines, reproducible challenge models, including RSV and influenza, and integrated GMP and clinical expertise to support faster proof of concept.

Announcement will help meet the rising demand for early-phase clinical studies, reinforcing SGS’s position as one of the few European CROs offering end-to-end human ADME programs.

Breakthrough heralds a significant advancement in vaccine and antiviral development, strengthening our role at the heart of Europe’s infectious disease research ecosystem.

Discover three quick wins to strengthen your post-ICH E6 (R3) implementation and boost inspection readiness.

Discover where you stand on your ICH E6 (R3) maturity journey and how to move from implementation to confident, inspection-ready practice.